The European Medicines Agency is misleading citizens into medical experimentation, experts warn
Doctors and scientists from 25 countries have today issued a rebuttal letter to the European Medicines Agency (EMA), following the regulator’s dismissal of their earlier warnings regarding COVID-19 vaccine dangers from clotting and bleeding.
Within days of the EMA receiving the group’s original letter on March 1st, outlining risks of blood disorders from COVID-19 vaccines, over a dozen countries suspended the AstraZeneca vaccine following deaths from clotting and bleeding, as the doctors had warned.
On March 23rd, however, the EMA dismissed the group’s concerns as relating to “minor” and “rare” events, concluding that “a positive benefit-risk balance has been established.”
The doctors and scientists have today hit back, accusing the EMA of misleading the public on the vaccines’ true risk-benefit profile. “Your reply of March 23 is unconvincing and unacceptable,” they wrote, noting that recorded cases of life-threatening cerebral venous thrombosis (CSVT) post-vaccination likely “represent just the tip of a huge iceberg”. Common reactions to vaccination, including headache, nausea, blurred vision and vomiting, they state, are symptoms of CSVT, and should be assessed as such, immediately.
Clotting and bleeding after vaccination can also “be expected to increase with each re-vaccination, and each intervening coronavirus exposure” the group warned. Over time “this renders both repeated vaccination and common coronaviruses dangerous to young and healthy age groups, for whom – in the absence of ‘vaccination’ – COVID-19 poses no substantive risk.
“Such is the real risk-benefit analysis of the COVID-19 ‘vaccines’. Either the EMA lacks the subject-matter expertise to appreciate the molecular science of this reality, or it lacks the medical ethics to act accordingly.”
The group, Doctors for Covid Ethics, which includes professors of immunology and microbiology, described the EMA’s responses to their concerns as “unscientific”, “vague”, and lacking credibility. The experts have offered to liaise with the agency to mitigate against vaccination risks and ethics violations, including helping the EMA to “craft a focussed pharmacovigilance plan.”
The group warned that continuing to administer inadequately tested gene-based COVID-19 vaccines represents dangerous medical experimentation, whose “true risks far outweigh any theoretical benefits”, reflecting “serious violations of medical ethics and citizens’ medical rights.”
“Misleading populations into accepting investigational agents such as the gene-based COVID-19 ‘vaccines’, or coercing them through ‘vaccine passports’, constitutes clear and egregious violations of the Nuremberg Code”, they caution.
The letter is addressed to Emer Cooke, Executive Director of the EMA, and was copied to the lawyer Reiner Fuellmich, Charles Michel, President of the Council of Europe, and Ursula von der Leyen, President of the European Commission.Link to Doctors for Covid Ethics rebuttal letter to EMA (April 1st):https://doctors4covidethics.medium.com/rebuttal-letter-to-european-medicines-agency-from-doctors-for-covid-ethics-april-1-2021-7d867f0121eLink to EMA letter to Doctors for Covid Ethics (March 23rd):https://doctors4covidethics.medium.com/reply-from-the-european-medicines-agency-to-doctors-for-covid-ethics-march-23-2021-d6760984dd06
Doctors for Covid Ethics is a group of over 100 doctors and scientists from 25 countries
Original Doctors for Covid Ethics letter to EMA (Delivered March 1st): https://doctors4covidethics.medium.com/urgent-open-letter-from-doctors-and-scientists-to-the-european-medicines-agency-regarding-covid-19-f6e17c311595
Video statement (March 11th) by Professor Sucharit Bhakdi, Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene: https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0
Doctors, scientists, lawyers and colleagues in allied disciplines can sign the open letters by sending their name, qualifications, areas of expertise and country of practice to:[email protected], with web verification (eg workplace or registration link, not for publication).